Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects

Bile acid synthesis defects (BASDs) comprise a group of rare diseases that can be severely disabling. Bile acid supplementation with 5 to 15 mg/kg cholic acid (CA) has been hypothesized to decrease endogenous bile acid production, stimulate bile secretion, and improve bile flow and micellar solubilization, thereby improving the biochemical profile and potentially slowing down disease progression. Currently, CA treatment is unavailable in the Netherlands, and CA capsules were compounded by the Amsterdam UMC Pharmacy from CA raw material. This study aims to determine the pharmaceutical quality a... Mehr ...

Verfasser: Yasmin Polak
Bart A. W. Jacobs
Natalja Bouwhuis
Carla E. M. Hollak
Maurice A. G. M. Kroon
Elles Marleen Kemper
Dokumenttyp: Artikel
Erscheinungsdatum: 2023
Reihe/Periodikum: Pharmaceutics, Vol 15, Iss 3, p 773 (2023)
Verlag/Hrsg.: MDPI AG
Schlagwörter: cholic acid / pharmacy compounding / bile acids / orphan drugs / product validation / stability testing / Pharmacy and materia medica / RS1-441
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27406323
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.3390/pharmaceutics15030773